Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans
Summary Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatm...
Gespeichert in:
Veröffentlicht in: | Andrology (Oxford) 2015-03, Vol.3 (2), p.287-292 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 292 |
---|---|
container_issue | 2 |
container_start_page | 287 |
container_title | Andrology (Oxford) |
container_volume | 3 |
creator | Walsh, T. J. Shores, M. M. Fox, A. E. Moore, K. P. Forsberg, C. W. Kinsey, C. E. Heckbert, S. R. Zeliadt, S. Thompson, M. L. Smith, N. L. Matsumoto, A. M. |
description | Summary
Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatment among those with low T levels in men treated at Veterans Affairs (VA) facilities in the Northwest US (VISN 20). We identified male Veterans aged 40–89 years and examined yearly proportions of men tested for T, found to have low T levels (total T |
doi_str_mv | 10.1111/andr.12014 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1675872102</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1675872102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4634-85bc7ada7977cf25060284697b84ef2ab63bbdc49dfee4cdad1e3b861316f0a13</originalsourceid><addsrcrecordid>eNp9kV9LwzAUxYMobsy9-AGk4IvIOpM0bdrHMf_CUBjqa0nT29HRJjPpHPv2puscuAcvgSTc3z055CB0SfCYuLoTKjdjQjFhJ6hPMeM-TSg_PZxJ0kNDa5fYVdwueo56NIxiFgVRH5VzkKAarzGgcuuVymvANto2YLSC3aVUi5FX6c3fTgXfUNmR594_GjEgmrrVFLVWC-8TXEMoe4HOClFZGO73Afp4fHifPvuzt6eX6WTmS-eI-XGYSS5ywRPOZUFDHGHqvCY8ixkUVGRRkGW5ZEleADCZi5xAkMURCUhUYEGCAbrpdFdGf62ds7QurYSqEgr02qYk4mHMKcHUoddH6FKvjXLuWoolMeE4dtRtR0mjrTVQpCtT1sJsU4LTNoO0zSDdZeDgq73kOqshP6C_P-4A0gGbsoLtP1Lp5PV-3on-AHy5ktE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1674981708</pqid></control><display><type>article</type><title>Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans</title><source>MEDLINE</source><source>Wiley Journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>Walsh, T. J. ; Shores, M. M. ; Fox, A. E. ; Moore, K. P. ; Forsberg, C. W. ; Kinsey, C. E. ; Heckbert, S. R. ; Zeliadt, S. ; Thompson, M. L. ; Smith, N. L. ; Matsumoto, A. M.</creator><creatorcontrib>Walsh, T. J. ; Shores, M. M. ; Fox, A. E. ; Moore, K. P. ; Forsberg, C. W. ; Kinsey, C. E. ; Heckbert, S. R. ; Zeliadt, S. ; Thompson, M. L. ; Smith, N. L. ; Matsumoto, A. M.</creatorcontrib><description>Summary
Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatment among those with low T levels in men treated at Veterans Affairs (VA) facilities in the Northwest US (VISN 20). We identified male Veterans aged 40–89 years and examined yearly proportions of men tested for T, found to have low T levels (total T < 280 ng/dL, free T < 34 pg/mL, or bioavailable T < 84 ng/dL), and subsequently treated with T from 2002 to 2011. We excluded men who had T treatment in the year prior and men with diagnoses of prostate or breast cancer. Treatment initiation was defined as the first prescription for T within a year following a low T test. From 2002 to 2011, the yearly population of eligible men in VISN 20 increased from 129 247 to 163 572. The proportion of men who had serum T tests increased from 3.2% in 2002 to 5.8% in 2011. Among the tested men, the percentage of men with low T levels increased from 35.0 to 47.3%. However, the proportion of men with low T levels who were given T treatment within a year decreased from 31.0 to 28.0%. Despite large increases in T testing, and detection of men with low T levels, there was a slight decrease in the proportion of men with low T levels who were treated with T. The decrease in T treatment during this time period contrasts with other studies and may be related to higher comorbidity in Veterans and/or VA formulary restrictions on the use of transdermal T formulations.</description><identifier>ISSN: 2047-2919</identifier><identifier>EISSN: 2047-2927</identifier><identifier>DOI: 10.1111/andr.12014</identifier><identifier>PMID: 25684636</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Hormone Replacement Therapy ; Humans ; Male ; Middle Aged ; testosterone ; Testosterone - administration & dosage ; trends ; United States ; Veterans</subject><ispartof>Andrology (Oxford), 2015-03, Vol.3 (2), p.287-292</ispartof><rights>2015 American Society of Andrology and European Academy of Andrology</rights><rights>2015 American Society of Andrology and European Academy of Andrology.</rights><rights>Andrology © 2015 American Society of Andrology and European Academy of Andrology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4634-85bc7ada7977cf25060284697b84ef2ab63bbdc49dfee4cdad1e3b861316f0a13</citedby><cites>FETCH-LOGICAL-c4634-85bc7ada7977cf25060284697b84ef2ab63bbdc49dfee4cdad1e3b861316f0a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fandr.12014$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fandr.12014$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25684636$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walsh, T. J.</creatorcontrib><creatorcontrib>Shores, M. M.</creatorcontrib><creatorcontrib>Fox, A. E.</creatorcontrib><creatorcontrib>Moore, K. P.</creatorcontrib><creatorcontrib>Forsberg, C. W.</creatorcontrib><creatorcontrib>Kinsey, C. E.</creatorcontrib><creatorcontrib>Heckbert, S. R.</creatorcontrib><creatorcontrib>Zeliadt, S.</creatorcontrib><creatorcontrib>Thompson, M. L.</creatorcontrib><creatorcontrib>Smith, N. L.</creatorcontrib><creatorcontrib>Matsumoto, A. M.</creatorcontrib><title>Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans</title><title>Andrology (Oxford)</title><addtitle>Andrology</addtitle><description>Summary
Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatment among those with low T levels in men treated at Veterans Affairs (VA) facilities in the Northwest US (VISN 20). We identified male Veterans aged 40–89 years and examined yearly proportions of men tested for T, found to have low T levels (total T < 280 ng/dL, free T < 34 pg/mL, or bioavailable T < 84 ng/dL), and subsequently treated with T from 2002 to 2011. We excluded men who had T treatment in the year prior and men with diagnoses of prostate or breast cancer. Treatment initiation was defined as the first prescription for T within a year following a low T test. From 2002 to 2011, the yearly population of eligible men in VISN 20 increased from 129 247 to 163 572. The proportion of men who had serum T tests increased from 3.2% in 2002 to 5.8% in 2011. Among the tested men, the percentage of men with low T levels increased from 35.0 to 47.3%. However, the proportion of men with low T levels who were given T treatment within a year decreased from 31.0 to 28.0%. Despite large increases in T testing, and detection of men with low T levels, there was a slight decrease in the proportion of men with low T levels who were treated with T. The decrease in T treatment during this time period contrasts with other studies and may be related to higher comorbidity in Veterans and/or VA formulary restrictions on the use of transdermal T formulations.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Hormone Replacement Therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>testosterone</subject><subject>Testosterone - administration & dosage</subject><subject>trends</subject><subject>United States</subject><subject>Veterans</subject><issn>2047-2919</issn><issn>2047-2927</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV9LwzAUxYMobsy9-AGk4IvIOpM0bdrHMf_CUBjqa0nT29HRJjPpHPv2puscuAcvgSTc3z055CB0SfCYuLoTKjdjQjFhJ6hPMeM-TSg_PZxJ0kNDa5fYVdwueo56NIxiFgVRH5VzkKAarzGgcuuVymvANto2YLSC3aVUi5FX6c3fTgXfUNmR594_GjEgmrrVFLVWC-8TXEMoe4HOClFZGO73Afp4fHifPvuzt6eX6WTmS-eI-XGYSS5ywRPOZUFDHGHqvCY8ixkUVGRRkGW5ZEleADCZi5xAkMURCUhUYEGCAbrpdFdGf62ds7QurYSqEgr02qYk4mHMKcHUoddH6FKvjXLuWoolMeE4dtRtR0mjrTVQpCtT1sJsU4LTNoO0zSDdZeDgq73kOqshP6C_P-4A0gGbsoLtP1Lp5PV-3on-AHy5ktE</recordid><startdate>201503</startdate><enddate>201503</enddate><creator>Walsh, T. J.</creator><creator>Shores, M. M.</creator><creator>Fox, A. E.</creator><creator>Moore, K. P.</creator><creator>Forsberg, C. W.</creator><creator>Kinsey, C. E.</creator><creator>Heckbert, S. R.</creator><creator>Zeliadt, S.</creator><creator>Thompson, M. L.</creator><creator>Smith, N. L.</creator><creator>Matsumoto, A. M.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201503</creationdate><title>Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans</title><author>Walsh, T. J. ; Shores, M. M. ; Fox, A. E. ; Moore, K. P. ; Forsberg, C. W. ; Kinsey, C. E. ; Heckbert, S. R. ; Zeliadt, S. ; Thompson, M. L. ; Smith, N. L. ; Matsumoto, A. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4634-85bc7ada7977cf25060284697b84ef2ab63bbdc49dfee4cdad1e3b861316f0a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Hormone Replacement Therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>testosterone</topic><topic>Testosterone - administration & dosage</topic><topic>trends</topic><topic>United States</topic><topic>Veterans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walsh, T. J.</creatorcontrib><creatorcontrib>Shores, M. M.</creatorcontrib><creatorcontrib>Fox, A. E.</creatorcontrib><creatorcontrib>Moore, K. P.</creatorcontrib><creatorcontrib>Forsberg, C. W.</creatorcontrib><creatorcontrib>Kinsey, C. E.</creatorcontrib><creatorcontrib>Heckbert, S. R.</creatorcontrib><creatorcontrib>Zeliadt, S.</creatorcontrib><creatorcontrib>Thompson, M. L.</creatorcontrib><creatorcontrib>Smith, N. L.</creatorcontrib><creatorcontrib>Matsumoto, A. M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Andrology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walsh, T. J.</au><au>Shores, M. M.</au><au>Fox, A. E.</au><au>Moore, K. P.</au><au>Forsberg, C. W.</au><au>Kinsey, C. E.</au><au>Heckbert, S. R.</au><au>Zeliadt, S.</au><au>Thompson, M. L.</au><au>Smith, N. L.</au><au>Matsumoto, A. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans</atitle><jtitle>Andrology (Oxford)</jtitle><addtitle>Andrology</addtitle><date>2015-03</date><risdate>2015</risdate><volume>3</volume><issue>2</issue><spage>287</spage><epage>292</epage><pages>287-292</pages><issn>2047-2919</issn><eissn>2047-2927</eissn><abstract>Summary
Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatment among those with low T levels in men treated at Veterans Affairs (VA) facilities in the Northwest US (VISN 20). We identified male Veterans aged 40–89 years and examined yearly proportions of men tested for T, found to have low T levels (total T < 280 ng/dL, free T < 34 pg/mL, or bioavailable T < 84 ng/dL), and subsequently treated with T from 2002 to 2011. We excluded men who had T treatment in the year prior and men with diagnoses of prostate or breast cancer. Treatment initiation was defined as the first prescription for T within a year following a low T test. From 2002 to 2011, the yearly population of eligible men in VISN 20 increased from 129 247 to 163 572. The proportion of men who had serum T tests increased from 3.2% in 2002 to 5.8% in 2011. Among the tested men, the percentage of men with low T levels increased from 35.0 to 47.3%. However, the proportion of men with low T levels who were given T treatment within a year decreased from 31.0 to 28.0%. Despite large increases in T testing, and detection of men with low T levels, there was a slight decrease in the proportion of men with low T levels who were treated with T. The decrease in T treatment during this time period contrasts with other studies and may be related to higher comorbidity in Veterans and/or VA formulary restrictions on the use of transdermal T formulations.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>25684636</pmid><doi>10.1111/andr.12014</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2047-2919 |
ispartof | Andrology (Oxford), 2015-03, Vol.3 (2), p.287-292 |
issn | 2047-2919 2047-2927 |
language | eng |
recordid | cdi_proquest_miscellaneous_1675872102 |
source | MEDLINE; Wiley Journals; Wiley Online Library (Open Access Collection) |
subjects | Adult Aged Aged, 80 and over Hormone Replacement Therapy Humans Male Middle Aged testosterone Testosterone - administration & dosage trends United States Veterans |
title | Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A00%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20trends%20in%20testosterone%20testing,%20low%20testosterone%20levels,%20and%20testosterone%20treatment%20among%20Veterans&rft.jtitle=Andrology%20(Oxford)&rft.au=Walsh,%20T.%20J.&rft.date=2015-03&rft.volume=3&rft.issue=2&rft.spage=287&rft.epage=292&rft.pages=287-292&rft.issn=2047-2919&rft.eissn=2047-2927&rft_id=info:doi/10.1111/andr.12014&rft_dat=%3Cproquest_cross%3E1675872102%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1674981708&rft_id=info:pmid/25684636&rfr_iscdi=true |